Samara Munoz
About Samara Munoz
Samara Munoz is a Cell Therapy Specialist III and Lead at Kite Pharma, where she has worked since 2021. She holds a Bachelor's degree in Biology from California State University-San Bernardino and has extensive experience in cGMP, GDP, and aseptic processing in the biotechnology field.
Work at Kite Pharma
Samara Munoz has held various positions at Kite Pharma, a leader in cell therapy. She began her tenure as a Cell Therapy Specialist I from 2018 to 2020, where she worked for two years in El Segundo, California. Following this role, she advanced to Cell Therapy Specialist I, Lead, from 2020 to 2021 for five months. In 2021, she served as Cell Therapy Specialist II, Lead, also for five months. Currently, she is employed as Cell Therapy Specialist III, Lead, a position she has held since 2021. Her roles have involved significant responsibilities in cell therapy production and compliance.
Education and Expertise
Samara Munoz earned her Bachelor's degree in Biology from California State University-San Bernardino, completing her studies from 2011 to 2016. She has developed strong expertise in cGMP (current Good Manufacturing Practice) and GDP (Good Distribution Practice), ensuring adherence to industry standards in biotechnology. Additionally, she possesses specialized skills in aseptic processing, which is essential for maintaining sterile conditions during cell therapy production. Her proficiency in developing and following Standard Operating Procedures (SOP) further underscores her qualifications in the field.
Background
Before her career at Kite Pharma, Samara Munoz worked as a Research Assistant at the California Institute for Regenerative Medicine in 2016 for six months. This role provided her with foundational experience in regenerative medicine, contributing to her knowledge and skills in cell therapy. Her educational background in biology has equipped her with the necessary scientific understanding to excel in her current role.
Achievements
Throughout her career, Samara Munoz has demonstrated a commitment to excellence in cell therapy. Her progression from Cell Therapy Specialist I to her current role as Cell Therapy Specialist III, Lead, reflects her growing expertise and leadership in the field. She has effectively contributed to the development and implementation of Standard Operating Procedures, ensuring compliance and quality in cell therapy processes.